Hear This — Zone Out on Zonisamide

The March 15-21, 2019 issue of the St. Louis Business Journal noted a $10.5 million Army grant to the Washington University in St. Louis Medical School to study the epilepsy drug Zonisamide to see if it could prevent hearing loss from loud noises. This seemed like such an imaginative stretch that we decided to look into it in more detail.

The justification given is that Zonisamide is conjectured to protect hearing loss when given ahead of exposure to loud noises. We wondered how this came about. We also note that other epilepsy drugs are psych-related, so we wondered if there was a psych drug connection here as well.

In a rat study, researchers proposed using a substance that blocks calcium channels to see if it could prevent hearing loss against loud noises. Zonisamide also blocks calcium channels. Gee, maybe Zonisamide can prevent hearing loss.

Zonisamide is the generic name used in the United States for a seizure drug whose common brand name is Zonegran. It was first used in Japan in the early 1970’s to treat so-called psychiatric disorders, and has been used off-label by psychiatrists in the U.S. as a mood stabilizer. The FDA approved it for seizures in 2000, although it is totally unknown as to how it works to prevent seizures. The FDA notes that taking this drug may increase the risk of depression, psychosis and suicidal thoughts or actions.

Using Zonisamide during pregnancy may present a significant risk to the fetus due to the possibility of birth defects.

Zonisamide was first studied in Japan in the 1970’s during exploratory research on drugs for psychiatric disorders. The drug alters the concentration of dopamine in the brain, but is apparently dosage dependent — that is, different dosages can increase or decrease dopamine concentrations, leading to unpredictable results.

Zonisamide is metabolized in the liver by Cytochrome P450 enzymes, so its side effects can be magnified in those persons with a genetic lack of these enzymes.

Typically we see that the psychiatric research community makes a guess about re-purposing some old drug so it can be re-used for a new patient population, guesses how it might work in the rat brain, then guesses how it might work in the human brain, each time asking for more funding to make further guesses, eventually leading to the FDA approving a new use for an old drug even though they still don’t know how it “works.”

While medicine has advanced on a scientific path to major discoveries and cures, psychiatry has never evolved scientifically and is no closer to understanding or curing mental problems, thus must continually seek to find new uses for old treatments.

While medicine has nurtured an enviable record of achievements and general popular acceptance, the public still links psychiatry to snake pits, straitjackets, and “One Flew Over the Cuckoo’s Nest.” Psychiatry continues to foster that valid impression with its development of such brutal treatments as ECT, psychosurgery, the chemical straitjacket caused by antipsychotic drugs, and its long record of treatment failures including Zonisamide as a mood stabilizer.

In over 40 years, “biological psychiatry” has yet to validate a single psychiatric condition/diagnosis as an abnormality/disease, or as anything neurological, biological, chemically imbalanced or genetic.

The drugs prescribed for psychiatric conditions, such as using Zonisamide as a mood stabilizer, only exacerbate the conditions they are supposed to treat. And when these drugs are used for other non-psychiatric conditions, they continue having the same adverse reactions, such as depression and suicide when Zonisamide is used for epilepsy. It will have the same adverse reactions if it is ever used for hearing loss. And they will still not know how it “works.”

We suggest that funding only be provided for workable medical treatments that dramatically improve and cure health and mental health problems. For more information, download and read the CCHR booklet “Psychiatric Hoax – The Subversion of Medicine – Report and recommendations on psychiatry’s destructive impact on health care.

Knock Yourself Out with Spravato (Esketamine)

A nasal spray version of the anesthetic drug ketamine was approved by the FDA on March 5, 2019 for treatment-resistant depression.

Janssen Pharmaceuticals says that the cost for a one-month course of treatment for Spravato (generic esketamine) will be between $4,720 and $6,785.

Esketamine is the S-enantiomer of ketamine, which means that it is one of the two mirror images of the chemical structure of ketamine, S (for the Latin sinister) being the left image. It enhances glutamine release in the brain. Glutamine is an amino acid used in the synthesis of proteins, among other things. In the brain, glutamine is used in the production of neurotransmitters. It is believed that glutamine plays a role in raising or lowering aggression levels.

Treatment requires that doses be taken, in conjunction with an oral antidepressant, in a doctor’s office or clinic, with patients monitored for at least two hours, and their experience entered in a registry.

Because of the risk of serious adverse outcomes and the potential for abuse and misuse of the drug, it is only available through a restricted distribution system. At least you can’t take it home with you.

The Spravato labeling contains a Boxed Warning that cautions that patients are at risk for sedation and difficulty with attention, judgment and thinking (dissociation), abuse and misuse, and suicidal thoughts and behaviors after administration of the drug.

Basically, it knocks you out so you don’t feel so depressed anymore. You don’t feel much of anything, actually, since you’ve just taken an anesthetic in the snout.

There were four phase 3 clinical trials; two of them failed to show any statistical improvement, but the drug was approved anyway because it was on the Fast Track and Breakthrough Therapy paths.

A 9/5/2018 update from Consumer Reports said, “All these drugs [Ketamine, Phenylbutazone, Chloramphenicol] are prohibited in beef, poultry, and pork consumed in the U.S. Yet government data obtained by Consumer Reports suggest that trace amounts of these and other banned or severely restricted drugs may appear in the U.S. meat supply more often than was previously known.”

Note that “depression” is not an actual medical illness; it is simply a symptom of some undiagnosed and untreated condition. A diagnosis of depression is a prime example of psychiatric fraud.

Any form of ketamine used to treat so-called depression is unethical and harmful, since it precludes the patient from finding out what is actually wrong and getting that treated. Psychiatrists pushing ketamine or esketamine are shameful drug pushers who are making a buck off people’s misfortune.

Go here for more information about alternatives to drugs.

Rexulti Fails to Get Results

REXULTI (generic brexpiprazole) is a prescription psychiatric drug from Otsuka Pharmaceutical Company and Lundbeck pharmaceutical company. Although it failed Phase II clinical trials for attention-deficit hyperactivity disorder (ADHD), it was approved by the U.S. Food and Drug Administration (FDA) in 2015 as an atypical antipsychotic and prescribed for the fake “disease” schizophrenia.

Then in 2018 the FDA approved it to treat symptoms of depression when antidepressants alone do not relieve symptoms.

The cost for Rexulti oral tablet 0.25 mg is around $1,166 for a supply of 30 tablets. It has similarities to Abilify, and apparently it was developed to replace Abilify when that drug’s patent expired in 2014.

Brexpiprazole affects the levels of the neurotransmitters dopamine and serotonin in the brain. It is thought to reduce dopamine output when dopamine concentrations are high and increase dopamine output when dopamine concentrations are low. It also activates serotonin receptors to increase serotonin levels in a manner thought to reduce hallucinogenic effects, which is a problem with all drugs that mess with serotonin in the brain.

The metabolism of the drug — that is, the mechanism which eventually eliminates it from the body — is mediated by Cytochrome P450 enzymes; people who are known poor metabolizers, i.e. those with a genetic lack of these enzymes, should be instructed to take half the usual dose, although this is rarely done, since the patient must first be tested for this genetic condition. It is estimated that 10% of Caucasians and 7% of African Americans are Cytochrome P450 deficient. The consequences for someone with this deficiency who takes this drug are an increased risk for the accumulation of the non-metabolized drug in the body and the resultant increase in adverse side effects such as depression, violence and suicide.

Drugs like Rexulti can raise the risk of death in the elderly, and it is not approved for the treatment of patients with dementia-related psychosis. This drug may also increase suicidal thoughts or actions in some children, teenagers, or young adults within the first few months of treatment. It is not approved for the treatment of people younger than 18 years of age.

Rexulti may cause other serious side effects, including: compulsive, uncontrollable behaviors such as gambling, shopping, binge eating and sex (the same as with Abilify); stroke in elderly people; Neuroleptic Malignant Syndrome; high fever; stiff muscles; confusion; sweating; changes in pulse, heart rate, or blood pressure; high blood sugar (hyperglycemia); weight gain; seizures; difficulty swallowing; uncontrolled body movements known as tardive dyskinesia. Tardive dyskinesia may not go away, even after one stops taking the drug, and tardive dyskinesia may also start some time after one stops taking the drug.

The real problem is that psychiatrists fraudulently diagnose life’s problems as an “illness”, and stigmatize unwanted behavior as “diseases.” Psychiatry’s stigmatizing labels, programs and treatments are harmful junk science; their diagnoses of “mental disorders” are a hoax – unscientific, fraudulent and harmful. All psychiatric treatments, not just psychiatric drugs, are dangerous. Find Out! Fight Back!

More About Dopamine

Since we discussed Serotonin in a previous newsletter, we should also discuss Dopamine.

Dopamine is a neurotransmitter that plays several important roles in the brain and body. A neurotransmitter is a chemical released by neurons (nerve cells) to send signals to other nerve cells. Its chemical formula is C8H11NO2. It belongs to a family of chemicals with high psychoactive properties.

Dopamine was first synthesized in 1910, first identified in the human brain in 1957, and its function as a neurotransmitter was first recognized in 1958. The name comes from a contraction of chemicals in its synthesis.

The anticipation of rewards increases the level of dopamine in the brain, and many addictive drugs increase dopamine release or block its reuptake into neurons following release.

Dopamine has other effects around the body:

  • helps widen blood vessels
  • helps increase urine output
  • helps regulate insulin production
  • helps to protect the gastrointestinal tract
  • helps control motor function
  • helps regulate aggression

Because it seems to be involved in the anticipation of rewards, it is seen as a chemical of pleasure or happiness. Most antipsychotic drugs are dopamine antagonists which reduce dopamine activity. Decreased levels of dopamine have also been associated with painful symptoms. Like serotonin, dopamine levels must be strictly regulated since both an excess and a deficiency can be problematic.

Side effects of dopamine include lowered kidney function and irregular heartbeats, addiction, and an overdose can be fatal. Cocaine, methamphetamine, Adderall, Ritalin, Concerta, MDMA (ecstasy) and other psychostimulants generally increase dopamine levels in the brain by a variety of mechanisms.

Dopamine and serotonin are both neurotransmitters; an imbalance of either one can have disastrous effects on health, mental health, digestion, sleep cycle, and so on. The serotonergic system has strong anatomical and functional interactions with the dopaminergic system. While they both affect a lot of the same parts of the body, they do so in distinct ways which are still not fully understood. In the brain in general, dopamine is an excitatory neurotransmitter and serotonin is an inhibitory neurotransmitter. The imbalance of these two chemicals can cause a number of disorders; thus, drugs which mess with either of these play Russian roulette with your brain.

Because both serotonin and dopamine are involved in regulating aggression in different ways, one can see that imbalances can lead to suicidal thoughts and behaviors, which is a common side effect of drugs which mess with these neurotransmitters.

Researchers still only conjecture about any relationship between mental symptoms and dopamine, and they are coming to understand that the results do not support the hype.

Psychiatrists have known since the beginning of psychopharmacology that their drugs do not cure any disease. Further, there is no credible evidence that mental health is genetic or linked to dopamine transport; these are just public relations theories to support the marketing and sale of drugs. The manufacturers of every such drug state in the fine print that they don’t really understand how it works. Psychiatric drugs are fraudulently marketed as safe and effective for the sole purpose of earning billions for the psycho-pharmaceutical industry.

These drugs mask the real cause of problems in life and debilitate the individual, so denying him or her the opportunity for real recovery and hope for the future. This is the real reason why psychiatry is a violation of human rights. Psychiatric treatment is not just a failure — it is routinely destructive to the individual and one’s mental health.

Mental Health and Social Justice

Social Justice: Fair and just relations between the individual and society, assigning rights and duties in the institutions of society, so that people receive basic societal benefits in return for their cooperation and participation.

In the Health Care field, social justice often means affordable access to ethical and effective health care.

In the field of Human Rights, we defer to the Universal Declaration of Human Rights, adopted by the United Nations General Assembly in 1948.

In Mental Health Care, we promote the Mental Health Declaration of Human Rights. All human rights organizations set forth codes by which they align their purposes and activities. The Mental Health Declaration of Human Rights articulates the guiding principles of CCHR and the standards against which human rights violations by psychiatry are relentlessly investigated and exposed. Under the banner of the Mental Health Declaration of Human Rights, tens of thousands of people around the globe have joined CCHR and taken to the streets to protest psychiatric drugging and other inhumane mental health practices.

Through stigmatizing labels, unscientific diagnoses, easy seizure commitment laws and brutal, depersonalizing “treatments,” thousands around the world suffer under psychiatry’s coercive system every day. It is a system that exemplifies human rights abuse. Modern psychiatry still has no scientific veracity and knows and admits it, but keeps up the charade for the sake of profit.

By depicting those they label mentally ill as a danger to themselves or others, psychiatrists have convinced governments and courts that depriving such individuals of their liberty, is mandatory for the safety of all concerned. Wherever psychiatry has succeeded in this campaign, extreme abuses of human rights have resulted.

One of CCHR’s primary concerns with psychiatry is its unscientific diagnostic system. Unlike medical diagnosis, psychiatrists categorize symptoms only, not disease. The Diagnostic and Statistical Manual of Mental Disorders (DSM–5) published by the American Psychiatric Association is notorious for low scientific validity.

Understanding this fraudulent diagnostic premise, we can see why psychiatry and psychology, entrusted with billions of dollars to eradicate the problems of the mind, have created and perpetuated them. Their drug panaceas cause senseless acts of violence, suicide, sexual dysfunction, irreversible nervous system damage, hallucinations, apathy, irritability, anxiousness, psychosis and death. And with virtually unrestrained psychiatric drugging of so many of our schoolchildren, it is no surprise that the largest age group of murderers today are our 15–to–19–year–olds.

Drugging children with addictive, violence-causing mind-altering psychotropic drugs is the “social justice” currently being employed by the psychiatric mental health industry. The rationale is, the drugged kids will now be able to compete with children from wealthier families who attend better schools. Rutgers psychiatrist Ramesh Raghavan, formerly at Washington University in St. Louis, chillingly said, “We are effectively forcing local community psychiatrists to use the only tool at their disposal [to ‘level the playing field’ in low-income neighborhoods], which is psychotropic medicine.”

The whole basis for this “social justice” program in low-income communities—that the ADHD drugs will improve school performance of kids and “level the playing field,” so they can compete academically with children from wealthier families—this whole program is based on a lie to begin with.

Meddling with the brains of children via these chemicals constitutes criminal assault, and it’s time it was recognized for what it is.

CCHR believes that everyone has the right to full informed consent regarding psychiatric drugs and other psychiatric treatments. Find out more by clicking here.

Crime and Mental Distress

A recent news report suggests that “Having a mental illness makes people more vulnerable to becoming the victims of a crime.”

We wondered about this, because it sounds just like the incessant and inane psychobabble coming out of the “psychology today” brain mill.

These results are suspicious because the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) lists “Victim of crime” as a mental disorder. So it’s hard to imagine that both “mental illness causes being a victim of crime” and “being a victim of crime causes mental illness.” It’s a no-win situation, and the fact that the DSM is a fraudulent machine used to sell psychiatric drugs does not make it more palatable.

The DSM-5 also has fourteen other diagnoses about being a victim in various abusive situations, and thirteen diagnoses about being the perpetrator of abuse or violence. It would seem that both victims and perpetrators are the focus of a lot of attention; so many ways to prescribe psychiatric drugs known to cause violence.

The study authors are using these questionable results to assert that people with mental illness are more likely to be victims rather than perpetrators of crime, giving the benefit of doubt to those who commit violence and further contributing to the perception of the “dangerous environment” so necessary to the existence of coercive psychiatry.

They are trying to prove that school shooters are not mentally ill, because this taint goes against the massive psychiatric public relations campaign to “stop the stigma of mental illness,” which is really a campaign underwritten by pharmaceutical companies to sell drugs.

The fact is, the real criminals here are psychiatrists and psychologists.

The soaring crime rate began to rise when psychiatrists and psychologists infiltrated the fields of education and law. When you put criminals in charge of crime, the crime rate rises.

If psychiatrists and psychologists actually knew what they were doing, the crime rate would drop. Instead, they conduct sham research about the relationship between crime and mental illness, instead of actually curing people and cementing the safety and security of society.

Real criminals would want to obfuscate the issues and point the finger away from themselves. Guess what? When the criminal mind accuses others, he is likely disclosing his own type of crime. And the fact is, psychiatric drugs cause violence, proven again and again as psych-drug-addled school shooters rage on.

Criminals think everyone else is a criminal, since they cannot envision people being decent. Psychiatrists and psychologists, focusing their attention on crime and illness, fail to observe human decency, and think there is nothing else but crime, deceit, and violence — all to be suppressed with harmful and addictive drugs, electroshock, psycho-surgery, involuntary incarceration, and restraints.

Recommendations

1. Legislative hearings should be held to fully investigate the correlation between psychiatric treatment and violence and suicide.

2. Toxicology testing for psychiatric and even illicit drugs should be mandatory in cases where someone has committed a mass shooting or other serious violent crime.

3. Train law enforcement officers, school security and teachers in the adverse effects of psychotropic drugs in order to recognize that irrational, violent and suicidal behavior in persons they may face could be influenced by these drugs.

4. No student shall be forced to take any psychotropic drug as a requisite of their education, in alignment with Title 20 of United States Code: Chapter 33, “Education of Individuals with Disabilities,” Subchapter II, (25) “Prohibition on mandatory medication.”

Psychiatric Drugs, School Violence, and Big Pharma Cover-Up

A study published June 12, 2018 from the University of Illinois at Chicago suggests that more than one-third (37.2%) of U.S. adults may be using prescription drugs that have the potential to cause depression or increase the risk of suicide.
[JAMA. 2018;319(22);2289-2298. doi:10.1001/jama.2018.6741]

Information about more than 26,000 adults from 2005 to 2014 was analyzed, along with more than 200 commonly prescribed drugs. However, many of these drugs are also available over the counter, so these results may underestimate the true prevalence of drugs having side effects of depression.

In other words, the use of prescription drugs, not just psychiatric drugs, that have depression or suicide as a potential adverse reaction is fairly common, and the more drugs one takes (called polypharmacy), the greater the likelihood of depression occurring as a side effect. “The likelihood of concurrent depression was most pronounced among adults concurrently using 3 or more medications with depression as a potential adverse effect, including among adults treated with antidepressants.”

Approximately 15% of adults who used three or more of these drugs concurrently experienced symptoms of depression or suicidal thoughts, compared with just 5% for those not using any of these drugs. Roughly 7.6% of adults using just one of these drugs reported a side effect of depression or suicidal thoughts during the study period, and 9% for those using two of these drugs. These results were the same whether the drugs were psychotropic or not. Depression was determined by asking nine questions related to the symptoms defined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5).

“Commonly used depression screening instruments, however, do not incorporate evaluations of prescribed medications that have depression as a potential adverse effect.” In other words, so-called depression screening tests can register false positives when the person is taking one or more of roughly 200 prescription drugs.

We thought we should dig a little deeper into this phenomenon.

First, understand that there is no depression “disease”. A person can certainly have symptoms of feeling depressed, but this is not a medical condition in itself. An example of a medical condition with a symptom of depression would be a vitamin B1 (thiamine) deficiency. You don’t fix it with an antidepressant; you fix it with vitamin B1. There are hundreds of medical conditions that may have mental symptoms, just as there are hundreds of drugs that can cause or worsen these symptoms. Finding the actual causes with appropriate clinical tests and then fixing what is found is the correct way to proceed.

This leads to a topic known as CYP450, which stands for Cytochrome P450 enzymes. Cytochrome means “cellular pigment” and is a protein found in blood cells. Scientists understand these enzymes to be responsible for metabolizing almost half of all drugs currently on the market, including psychiatric drugs.

These are the major enzymes involved in drug metabolism, which is the breakdown of drugs in the liver or other organs so that they can be eliminated from the body once they have performed their function.

If these drugs are not metabolized and eliminated once they have done their work, they build up and become concentrated in the body, and then act as toxins. The possibility of harmful side effects, or adverse reactions, increases as the toxic concentration increases. The ballpark estimate is that each year 2.2 million Americans are hospitalized for adverse reactions and over 100,000 die from them.

Some people are deficient in CYP450 or have diminished capacity to metabolize these drugs, which may be a genetic or other issue. Individuals with no or poorly performing CYP450 enzymes are much more likely to suffer the side effects of prescription drugs, particularly psychiatric drugs known to have side effects of depression, violence and suicide.

These metabolic processes are immature at birth and up to three years old, and this may result in an increased risk for drug toxicity in infants and young children. Furthermore, certain drugs or certain excipients in vaccines may inhibit activation of CYP450 enzymes, again resulting in an increased risk for the accumulation of non-metabolized drugs and the resultant increase in adverse side effects such as depression, violence and suicide.

The side effects caused by a CYP450 deficiency and its subsequent failure to metabolize any one of hundreds of drugs can then be misdiagnosed as a mental illness, the patient then being prescribed more psychiatric drugs in a mistaken attempt to treat those side effects, further complicating the problems.

It is estimated that 10% of Caucasians and 7% of African Americans are Cytochrome P450 deficient.

The psychiatric and pharmaceutical industries have been aware of this phenomenon for some time, yet they have continued to push psychiatric drugs at an ever increasing rate, and the dramatic increase in symptoms of depression, suicide, and school violence is a direct result.

No one should be prescribed these types of drugs without adequate testing for a CYP450 deficiency, in order to determine their risk potential for adverse reactions. The test is not “standard of care” so one has to ask for it; but beware, they will still recommend an alternative drug if the original one cannot be easily metabolized. Better yet, stop prescribing all psychiatric drugs and find out with proper medical, clinical tests what the real problems are and treat those. Full informed consent is always indicated.

Any psychiatrist or pharmaceutical company that has knowingly withheld evidence about the relationship between CYP450 enzymes and drug side effects should be subject to both prosecution and litigation.

Medical students should be educated about these relationships.

For more information click on any of the links in this newsletter.

“Shoot ’em up” Is No Longer Just for Westerns

Once is happenstance, twice is coincidence, three times is enemy action.”
[with thanks to Charles Stross in The Apocalypse Codex.]

The Citizens Commission on Human Rights (CCHR), a mental health watchdog that has investigated school and other mass shootings since the Columbine High School Shooting in 1999, warns about pouring hundreds of millions of dollars into more mental health services in response to the Marjory Stoneman Douglas High School shooting on Valentine’s Day.

An investigation into the shooting must include what psychotropic drugs the alleged shooter, Nikolas Cruz, has been prescribed and the fact that he had apparently undergone “behavioral health” treatment which did nothing to prevent the murderous outcome. A 2016 Florida Department of Children and Family Services report indicated that he was regularly taking “medication” for Attention Deficit Hyperactivity Disorder (ADHD); these types of psychotropic drugs are known to have violence and suicide as potential side effects.

CCHR International’s investigation into school violence reveals that at least 36 school shootings and/or school-related acts of violence have been committed by those taking or withdrawing from psychiatric drugs resulting in 172 wounded and 80 killed.

At least 27 international drug regulatory agency warnings have been issued on psychiatric drugs being linked to mania, violence, hostility, aggression, psychosis, and homicidal ideation (thoughts or fantasies of homicide that can be planned).

Cruz, 19, charged over the Parkland, Florida shooting, is a prime example of the failure of the mental health system. Expecting better mental health treatment to solve these problems is a forlorn hope, since it promises something that has not and cannot be delivered.

Pouring more funds into a mental health system that keeps failing and continues to use “treatments” that may induce violent and suicidal behavior in a percentage of those taking them, is a recipe for future disaster. Recognize that the repeated violence caused by psychiatric drugging of school children is neither happenstance nor coincidence, and is in fact an enemy action, and the enemy is psychiatry.

The survivors of the Parkland shooting, the families of those killed and the community at large deserves answers and accountability. CCHR is calling on families with knowledge of a loved one who has experienced treatment abuse and for whistleblowers who have concerns about any behavioral facility to contact CCHR by reporting the abuse here.

For more information read this news release.

The White House Taking Action on Veteran Suicides

Presidential Executive Order on Supporting Our Veterans During Their Transition From Uniformed Service to Civilian Life (January 9, 2018)

Relevant quotes from the Presidential Executive Order:

“It is the policy of the United States to support the health and well-being of uniformed service members and veterans. … our Government must improve mental healthcare and access to suicide prevention resources available to veterans … Veterans, in their first year of separation from uniformed service, experience suicide rates approximately two times higher than the overall veteran suicide rate. To help prevent these tragedies, all veterans should have seamless access to high-quality mental healthcare and suicide prevention resources as they transition, with an emphasis on the 1-year period following separation.”

Mr. Trump’s order makes a wide range of mental health services available to all veterans as they transition back to civilian society.

It sounds nice; it sounds appropriate; it sounds like everyone would support it. What’s the “but?”

But, in this society at this time, “mental health services” generally means psychotropic drugs. “Psychotropic” means “acting on the mind; affecting the mental state,” meaning that that the drugs change brain function and result in alterations in perception, mood, consciousness or behavior. They don’t actually fix anything, they just suppress both good and bad feelings.

There is another “but” — these drugs also have serious adverse side effects, and three of the most troubling of these are addiction, violence and suicide.

So the preferred “treatment” for veterans’ mental health and suicide are drugs which have suicide as a side effect. Which came first? The drugs, of course.

The psychiatric industry protests that they have many services available, not just drugs. Well, let’s see —

  1. They can talk about it, which they call “cognitive-behavioral therapy” — which is when a therapist evaluates for the patient and tells them what behaviors they need to change.
  2. They can cut out part of the brain with surgery; like you’re going to let them do that to you.
  3. They can shock the brain with high-voltage electricity; and if you believe that is going to help, we’ve got a bridge in Brooklyn we know you’ll be eager to buy; and once you’ve had a course of electroshock treatments you won’t remember we told you so.
  4. They can wire your vagus nerve, which controls such things as heart rate, to send short bursts of electricity directly into the brain. Uh-huh.
  5. They can wrap a huge magnet around your head, called transcranial magnetic stimulation, and zap the brain with induced electric currents. You might as well just shoot yourself. Whoops, many veterans are already doing that.
And then there are all the other efforts to prescribe “breakthrough” drugs, since the normal psychotropic ones are so damaging — drugs like marijuana, magic mushrooms, MDMA (Ecstasy), Ketamine, etc. Talk about desperation!

What are the alternatives? What can the White House and the Veterans Administration do that would actually be effective help for veterans? If enough people tell the White House and the VA about the horrors of psychiatric treatments and the availability of workable alternatives, they might start to listen. Can you call the White House and make a comment about this?

Contact the White House at https://www.whitehouse.gov/contact/ and/or leave your comments at 202-456-1111. Contact the various key White House personnel mentioned in the President’s Executive Order as well, but WH musical chairs may make it difficult to nail down their names and contact information. Last we knew, here are some of the names:

Director of the White House Domestic Policy Council- Andrew Bremberg
Deputy Director of the Domestic Policy Council – either Paul Winfree or Lance Leggitt
Healthcare Policy- Katy Talento
Secretary of Defense – Gen. James Mattis, USMC
Secretary of Homeland Security – Kirstjen Nielsen
Secretary of Veterans Affairs – Dr. David J. Shulkin

You can reference the CCHR STL blog here for more information.

GAO Will Review PTSD Treatment in the VA

U.S. Representatives Mike Coffman (R-CO) and Ann McLane Kuster (D-NH) requested the Government Accountability Office to study how heavily the Veterans Administration relies upon psychotropic drugs to treat their patients for so-called Post-Traumatic Stress Disorder (PTSD). The GAO agreed September 27, 2017 to conduct the review.

Many people are concerned that the use of psychotropic drugs is a contributing factor to the alarming rate of suicides among veterans.

Express your concern about this by contacting:
Rep. Mike Coffman – https://coffman.house.gov/contact/ and jeremy.lippert@mail.house.gov
Rep. Ann McLane Kuster – https://kuster.house.gov/contact/email-me and lisbeth.zeggane@mail.house.gov
GAO – contact@gao.gov; youngc1@gao.gov; congrel@gao.gov; spel@gao.gov

Today, PTSD has become blurred as a catch-all diagnosis for some 175 combinations of symptoms, becoming the label for identifying the impact of adverse events on ordinary people. This means that normal responses to catastrophic events have often been interpreted as mental disorders when they are not.

The favored “treatment” for PTSD is psychotropic drugs known to cause violence and suicide.

According to the CCHR documentary The Hidden Enemy: Inside Psychiatry’s Covert Agenda, all evidence points in one direction: the soaring rates of psychiatric drug prescribing since 2003. Known drug side effects of these drugs such as increased aggression and suicidal thinking are reflected in similar uptrends in the rates of military domestic violence, child abuse and sex crimes, as well as self-harm.

Pull the string further and you’ll find psychiatrists ever widening the definitions of what it means to be “mentally ill,” especially when it comes to PTSD in soldiers and veterans. In psychiatry, diagnoses of psychological disorders such as PTSD, personality disorder and social anxiety disorder are almost inevitably followed by the prescription of at least one harmful and addictive psychiatric drug.

Psychiatrists know that their drugs do not actually cure anything, but merely mask symptoms. They are well aware of their many dangerous side effects, including possible addiction. If you are in the military, a veteran, a member of a military or veteran support group, or family or associate of a member of the military or a veteran, you quality for a free Hidden Enemy DVD.

Also watch the documentary online here.